drugset / Trial / NCT01213173
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of Succinate Metoprolol(Betaloc ZOK®) (95 - 190 mg) on heart rate in the Stable angina patients.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 95 mg | — |
| Subject | Metoprolol | Other / unclassified | 190 mg | — |
Indications
No indication recorded.